Von Willebrand factor-binding protein (VWbp), secreted by Staphylococcus aureus, displays secondary structural homology to the 3-helix bundle, D1 and D2 domains of staphylocoagulase (SC), a potent conformational activator of the blood coagulation zymogen, prothrombin (ProT). In contrast to the classical proteolytic activation mechanism of trypsinogen-like serine proteinase zymogens, insertion of the first 2 residues of SC into the NH 2-terminal binding cleft on ProT (molecular sexuality) induces rapid conformational activation of the catalytic site. Based on plasma-clotting assays, the target zymogen for VWbp may be ProT, but this has not been verified, and the mechanism of ProT activation is unknown. We demonstrate that VWbp activates ProT conformationally in a mechanism requiring its Val 1 -Val 2 residues. By contrast to SC, full time-course kinetic studies of ProT activation by VWbp demonstrate that it activates ProT by a substrate-dependent, hysteretic kinetic mechanism. VWbp binds weakly to ProT (K D 2.5 M) to form an inactive complex, which is activated through a slow conformational change by tripeptide chromogenic substrates and its specific physiological substrate, identified here as fibrinogen (Fbg). This mechanism increases the specificity of ProT activation by delaying it in a slow reversible process, with full activation requiring binding of Fbg through an exosite expressed on the activated ProT*⅐VWbp complex. The results suggest that this unique mechanism regulates pathological fibrin (Fbn) deposition to VWF-rich areas during S. aureus endocarditis.
Von Willebrand factor-binding protein (VWbp), secreted by Staphylococcus aureus, displays secondary structural homology to the 3-helix bundle, D1 and D2 domains of staphylocoagulase (SC), a potent conformational activator of the blood coagulation zymogen, prothrombin (ProT). In contrast to the classical proteolytic activation mechanism of trypsinogen-like serine proteinase zymogens, insertion of the first 2 residues of SC into the NH 2-terminal binding cleft on ProT (molecular sexuality) induces rapid conformational activation of the catalytic site. Based on plasma-clotting assays, the target zymogen for VWbp may be ProT, but this has not been verified, and the mechanism of ProT activation is unknown. We demonstrate that VWbp activates ProT conformationally in a mechanism requiring its Val 1 -Val 2 residues. By contrast to SC, full time-course kinetic studies of ProT activation by VWbp demonstrate that it activates ProT by a substrate-dependent, hysteretic kinetic mechanism. VWbp binds weakly to ProT (K D 2.5 M) to form an inactive complex, which is activated through a slow conformational change by tripeptide chromogenic substrates and its specific physiological substrate, identified here as fibrinogen (Fbg). This mechanism increases the specificity of ProT activation by delaying it in a slow reversible process, with full activation requiring binding of Fbg through an exosite expressed on the activated ProT*⅐VWbp complex. The results suggest that this unique mechanism regulates pathological fibrin (Fbn) deposition to VWF-rich areas during S. aureus endocarditis.
coagulation ͉ proteinases ͉ Staphylococcus aureus ͉ zymogens ͉ hysteresis T he tightly regulated balance among procoagulant, anticoagulant, and fibrinolytic pathways in blood is kinetically controlled by the rates of proteolytic activation of zymogens of the chymotrypsinogen family. The classical proteolytic activation mechanism is initiated by cleavage at Arg 15 -Ile 16 (chymotrypsinogen numbering), followed by insertion of the Ile 16 NH 2 terminus into the NH 2 -terminal-binding cleft, and formation of a critical salt bridge with Asp 194 (1) (2) (3) . This triggers folding of segments of the catalytic domain, which forms the substratebinding site and oxyanion hole required for activity. The mechanism is fundamentally conformational in that zymogens are in unfavorable equilibrium between conformationally active forms that vary in equilibrium constants from 10 8 (trypsinogen) (4) to Ϸ7 (single-chain tissue-type plasminogen activator) (5) . Dipeptides that mimic the conserved NH 2 termini (Ile-Val or Val-Val) induce structural changes in trypsinogen toward the active proteinase conformation (1, 3) , and tight-binding inhibitors like bovine pancreatic trypsin inhibitor convert trypsinogen fully to the conformation of trypsin (3) .
By contrast, staphylocoagulase (SC) from Staphylococcus aureus activates the coagulation zymogen prothrombin (ProT) nonproteolytically, and formation of the tightly bound ProT⅐SC complex initiates direct cleavage of fibrinogen (Fbg) into fibrin (Fbn) (6, 7) . The ProT⅐SC(1-325) complex expresses a new exosite that mediates specific substrate recognition of Fbg, whereas full-length SC(1-660) also interacts with Fbg as an adhesion protein through COOH-terminal repeat sequences (8, 9) . This benefits the pathogen by facilitating escape from the host defense system through formation of protective Fbn-plateletbacteria vegetations in acute bacterial endocarditis (10) .
Von Willebrand factor-binding protein (VWbp), also secreted by S. aureus, was first identified by phage-display of an S. aureus (Newman) DNA library screened against von Willebrand factor (VWF) (11) , leading to its classification as an adhesion protein.
Binding to both immobilized and soluble VWF is mediated by a 26-aa region within VWbp (11) , but the physiological significance of this interaction has not been established. VWbp was further recognized as a putative member of the bifunctional zymogen activator and adhesion protein (ZAAP) family for which SC is the prototype (12, 13) . It was subsequently postulated to be an SC homolog from its 25% sequence identity with SC and clotting of human plasma (14) .
The structure of the NH 2 -terminal half of SC, SC(1-325), is unique, with a characteristic elbow-like fold between 2 domains (D1-D2) comprised of 3-helix bundles (13) . Secondary structure modeling of the corresponding D1-D2 domains of VWbp(1-263) revealed a high degree of similarity (13) . Structural and kinetic studies of SC demonstrated insertion of the first 2 NH 2 -terminal residues of SC into the NH 2 -terminal-binding cleft in the ProT catalytic domain (13) . The NH 2 terminus forms a salt bridge with Asp 194 (13) , triggering the conformational change that activates the catalytic site. This ''molecular sexuality'' mechanism (1) has only been demonstrated for SC and the plasminogen activator streptokinase (15) , whereas essentially nothing is known about the mechanism of plasma clotting by VWbp.
The specific interactions responsible for the procoagulant activity of VWbp have not been defined, and the mechanism of its activation of ProT is unknown. In the present studies, we defined the molecular basis and unusual hysteretic kinetic mechanism of ProT activation by VWbp and identified Fbg as its specific substrate, which are postulated to play a role in the pathology of S. aureus infection.
incorporation of fluorescein into ProT only (Fig. 1, lanes 4) , with no proteolysis of the zymogen for either VWbp(1-263) or VWbp(1-474). Stringent controls omitting one of the steps of the labeling scheme confirmed that all of the labeling steps were necessary for probe incorporation (Fig. 1, lanes 3 and 5-7 ).
Activation of Pre 1 by the NH2-Terminal Insertion Mechanism. To ascertain whether VWbp activates ProT through the molecular sexuality mechanism, VWbp(1-474) was compared in kinetic assays of prethrombin 1 (Pre 1; ProT lacking the fragment 1 domain) activation to the NH 2 -terminal deletion mutants, VWbp(2-474) and VWbp . Initial rates of ProT activation could not be used quantitatively in this analysis because of their inherent curvature, whereas initial rates of Pre 1 activation by VWbp(1-474) were nearly linear. Deletion of the first NH 2 -terminal Val residue of VWbp reduced its activity at saturation Ϸ78%, whereas deletion of both Val 1 and Val 2 completely inactivated VWbp (Fig. 2) . Qualitatively similar results were obtained with ProT, with no detectable activity for VWbp (17, 18) . The excellent nonlinear least-squares fits indicated that the curvature initiated by substrate was a single exponential process. The observed rate constants increased hyperbolically with increasing VWbp(1-263) concentration and decreased with increasing substrate concentration. This ruled out a mechanism involving an unfavorable preexisting conformational equilibrium between active and inactive forms of ProT in which VWbp(1-263) bound only the active form that also bound substrate. This mechanism predicts a decrease in k obs with increasing VWbp(1-263) concentration, rather than the observed increase. The decease in k obs with increasing substrate concentration suggested that substrate binding followed the slow conformational change.
To evaluate the mechanism further, 2 chromogenic substrates (D-Phe-Pip-Arg-pNA and Tosyl-Gly-Pro-Arg-pNA) having a Ϸ5-fold difference in K m for thrombin were used in full timecourse activation progress curve analysis. Progress curves collected as a function of substrate and VWbp(1-263) concentration were analyzed simultaneously by numerical integration of the differential rate equations for candidate mechanisms combined with nonlinear least-squares fitting with DYNAFIT (19) . The hysteretic mechanism shown in Scheme 1 produced a consistent fit to the data for both substrates (Fig. 3) , with the parameters listed in Table 1 . To obtain the best fit, product inhibition was included in the mechanism as a single binding step (not included in Scheme 1). Including a conformational equilibrium succeeding product binding did not improve the fit. In Scheme 1, the initial inactive ProT⅐VWbp(1-263) complex is formed with low affinity (K D 2.2-2.4 M) in a rapid equilibrium step. ProT⅐VWbp(1-263) is in an unfavorable, slow equilibrium with active ProT*⅐VWbp , and tight binding of substrate to the ProT*⅐VWbp (1-263) complex shifts the equilibrium toward the active form. The slow shift in equilibrium increases the rate of substrate hydrolysis, responsible for the upward curvature of the progress curves. The fitted parameters showed that both substrates exhibited 2-to 4-fold-lower K m for the ProT*⅐VWbp(1-263) complex compared with thrombin ( Table 1 ). The analysis also revealed an unfavorable equilibrium constant (K con 9 Ϯ 1 and 9 Ϯ 6) for the slow conformational change, and excellent agreement between the individual rate constants (k C1 , k C2 ) to form ProT*⅐VWbp(1-263) for the 2 substrates (Table 1 ). In addition, the apparent affinity (K D ) of ProT for formation of the Table 1) . Results obtained with other substrates with K m in the 100-to 300-M range were not fit well by the mechanism in Scheme 1 because of the importance of obtaining near-saturation within the experimentally accessible concentration range. A more complex mechanism involving significant activity for the inactive complex failed to produce consistent fits or reasonable parameters. The possibility that autocatalytic cleavage of ProT to Pre 1, previously reported for SC (6) (1-263), implicating the hysteretic mechanism in recognition of the natural substrate. Although an exhaustive survey of other potential substrates was not done, kinetic assays revealed no activation of the thrombin substrates, protein C, factor V, or factor XI, or 2 other coagulation zymogens (factor IX and factor X) by ProT⅐VWbp(1-263). In addition, the thrombin-selective serpins antithrombin and heparin cofactor II did not inhibit the activity of the ProT⅐VWbp(1-263) complex in the presence or absence of heparin.
Discussion
Our results support the conclusion that VWbp is a previously uncharacterized nonproteolytic ProT activator that utilizes molecular sexuality and employs a unique substrate-activated hysteretic kinetic mechanism. Active site-specific labeling of ProT with a fluorescent probe in mixtures with VWbp(1-263) or VWbp(1-474) provided a direct demonstration of nonproteolytic activation of the zymogen. These experiments also indicate that the SC(1-325)-homologous D1 and D2 domains of VWbp(1-263) are sufficient for ProT activation. Total loss of activity accompanying deletion of the first 2 NH 2 -terminal residues of VWbp shows that it activates the ProT derivative, Pre 1, and ProT through the molecular sexuality mechanism. Table 1 is represented by solid lines. Tosyl-Gly-Pro-Arg-pNA
Our studies and previous reports indicate that SC(1-325) has the same maximal chromogenic substrate activity as SC(1-660) (22) . In contrast, ProT activation by full-length VWbp(1-474) displays higher activity than VWbp(1-263), although VWbp(1-474) also shows hysteresis. The finding that Pre 1 activation by VWbp(1-474) shows less hysteresis than ProT implicates the fragment 1 domain in the mechanism. The COOH-terminal region of VWbp is associated with the higher activity of the ProT⅐VWbp complex, possibly through additional interactions that increase substrate affinity and/or hydrolysis. Kinetic analysis of ProT activation by VWbp demonstrates a hysteretic model of enzyme activation, where there is a slow response to an abrupt stimulus that controls the observed rate of catalysis (17) . The hysteretic kinetic concept is applicable to a number of enzymes involved in metabolic regulation and can result from isomerization, ligand displacement, or enzyme polymerization (17) . Although slow hysteretic transitions have been examined for several monomeric enzymes (18, 23) , our results demonstrate hysteresis in serine proteinase zymogen activation.
As predicted from the kinetic model (Scheme 1), the K D for formation of the inactive ProT⅐VWbp(1-263) complex and the rate constants for the slow conformational change were independent of the structures and kinetic parameters for 2 tripeptidepNA substrates. The relatively low affinity of ProT⅐VWbp(1-263) complex formation revealed an additional disparity between the behavior of VWbp(1-263) and SC. Whereas SC(1-325) binds to native ProT with extremely high affinity (K D 17-72 pM) (24), the initial affinity of ProT and VWbp(1-263) was 2.2-2.4 M from the kinetic analysis and 2.5 M from competitive binding experiments. The kinetic mechanism suggests that VWbp(1-263) binds the native ProT zymogen with a weaker affinity than the zymogen with a substrate occupying the active site. The weak affinity of VWbp(1-263) for ProT and the hysteretic generation of proteolytic activity represent a unique regulatory mechanism in which the initially low affinity prevents premature activation of ProT, and the hysteresis delays the response to substrate, restricting Fbn formation. The hysteretic mechanism thus functions to increase the specificity of VWbp for Fbn formation compared with SC.
The NH 2 -terminal insertion pocket, catalytic site, and certain regulatory exosites on coagulation proteinases are allosterically linked (25, 26) . In the classical zymogen activation mechanism, these sites are rapidly expressed as part of the zymogen-toproteinase conformational transition. Based on the linkage between these sites, the hysteretic conformational change between inactive and active forms of ProT⅐VWbp complex represents these events as a slow transition, unique among zymogen activation mechanisms. The need for substrate binding to complete the conformational change indicates that either NH 2 -terminal insertion is an unfavorable intramolecular equilibrium or that the VWbp Val-Val NH 2 terminus inserts normally but does not result in an optimal structure to effect full activation. Mutation of VWbp(1-474) Val 1 to Ile to mimic the SC NH 2 -terminal dipeptide did not detectably affect the hysteretic behavior, indicating that the difference in the dipeptides is not responsible. For ␣-chymotrypsin, interconversion of an inactive conformation at high pH to the active form at neutral pH is controlled by protonation of the ␣-amino group of Ile 16 (27) . In pH-jump experiments, the rate constants for formation of the chymotrypsin active site correspond to k C1 and k C2 of 3 s Ϫ1 and 0.6 s Ϫ1 , respectively, and K con of 0.2 (27) . If the values for chymotrypsin are taken as representative of the rate of NH 2 -terminal insertion and activation of the catalytic site for ProT, the values for ProT⅐VWbp(1-263) are 590-fold (k C1 ) and 12-fold (k C2 ) slower. This suggests that the activating conformational change for ProT⅐VWbp(1-263) is not limited by the rate constants for insertion and conformational activation, but by additional interactions of ProT with VWbp(1-263) that slow the activation process.
Screening of other coagulation zymogens for direct activation by VWbp indicates that it does not activate protein C, factor IX, factor X, or factor XII. The finding that VWbp binds to the low-affinity precursor form of exosite I on ProT, and the established role of exosite I in thrombin interactions with protein substrates (including Fbg), inhibitors, and regulatory proteins (25) indicates that ProT⅐VWbp will exhibit highly restricted substrate and inhibitor specificity, preventing interactions with thrombomodulin, factor V, factor VIII, heparin cofactor II, and protease activated receptor-1 (25) . Fbg substrate recognition by activation of proexosite I in the ProT⅐VWbp complex is not possible because this site is blocked by VWbp. Neither VWbp nor ProT alone bind Fbg, indicating that Fbg substrate recognition by the ProT⅐VWbp complex is mediated by expression of a new exosite. The occupation of exosite II in ProT by the fragment 2 domain restricts further the substrate specificity of VWbp by blocking heparin-accelerated inhibition by antithrombin, as well as exosite II-dependent binding of factor V, factor VIII, and the platelet receptor GPIb␣ (25) . The studies show that Fbg is the only established substrate of the ProT⅐VWbp(1-263) complex that binds with sufficient affinity to shift the hysteretic conformational equilibrium to the active complex. The lag observed in the time course of Fbg clotting assays initiated with ProT-VWbp(1-263) mixtures suggests that the dependence of the hysteretic kinetic mechanism on a protein substrate restricts activation of ProT by VWbp to areas rich in Fbg. Localized depletion of Fbg in an endocarditis vegetation may result in shutting off ProT⅐VWbp by the more rapid reversal of the conformational change. Additional results with VWbp(1-474) show no significant effect of the plasma concentration of VWF (150 nM) on the hysteretic mechanism of ProT activation, for either untreated VWF or the extended conformation induced by vortexing VWF under conditions that enhance VWF cleavage by ADAMTS13 (28) .
The results of this study characterize the coagulation-specific molecular mechanisms behind a potential virulence factor from S. aureus. As the first additional member of the ZAAP family of bifunctional conformational zymogen activators and adhesion proteins, elucidation of the role of VWbp in activation of coagulation during endocarditis may aid in the development of mechanism-based therapies. Further clarification of the interactions of VWbp with both ProT and plasma adhesion proteins will offer insight into how VWbp may serve to specifically localize ProT activation in the course of S. aureus infection. This raises the question of why are there 2 ProT activators, VWbp and SC, secreted by S. aureus. All S. aureus strains that contain the gene for VWbp also contain the gene for SC (11) . The evolutionary advantage responsible for maintaining both activators is likely because of the differences in the adhesion protein targets and the kinetic mechanisms of ProT activation. In the context of endocarditis, the initial vascular injury of the endothelium on heart valves at high shear rates activates coagulation, with VWF mediating the early stages of platelet accumulation by tethering through exposed subendothelial collagen and the platelet GPIb␣ receptor, followed by conversion of Fbg to Fbn within the thrombus (29) . Additional binding of platelets by VWF occurs after platelet activation by thrombin and depends on the platelet integrin ␣ IIb ␤ 3 (30) . S. aureus concurrently adheres to multiple extracellular matrix proteins, including fibronectin, collagen, and Fbn, through microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) (31) . Through initial association with VWF at transient sites of vascular injury, VWbp could restrict pathologic Fbn deposition to focal points in the vasculature, establishing new locations for bacterial dissemination. Thus, VWbp may catalyze the first assault in Fbn deposition, followed by rampant SC-mediated Fbn deposition and vegetation growth. at 405 nm and 25°C. Pre 1 was incubated with VWbp for 20 min in 50 mM Hepes, 110 mM NaCl, 5 mM CaCl2, 1 mg/mL polyethylene glycol (PEG) 8000 (pH 7.4) before substrate addition. The maximum velocity was determined by nonlinear least-squares analysis of the hyperbolic titrations.
ProT Activation Kinetics. Progress curves for hydrolysis of 2 thrombin-specific chromogenic substrates (D-Phe-Pip-Arg-pNA and Tosyl-Gly-Pro-Arg-pNA) by mixtures of ProT and VWbp(1-263) were measured in the buffer described above. Full time-course assays were performed under both saturating and limiting substrate concentrations, with continuous data collection for 2 h, or until A405 nm ϭ 1.0. Proteins were incubated for 20 min at 25°C before initiating the reactions by addition of substrate. Analysis of individual progress curves was performed on data truncated to Յ10% substrate depletion by fitting the integrated equation for the classical hysteresis mechanism,
where Pt is the product formed at time t, vf, and v0 are the final and initial velocities, and kobs is the observed first-order rate constant (17) . This equation is applicable only under conditions of minimal substrate depletion and product inhibition. Analysis of progress curves from full time-course assays under saturating and substrate depletion concentrations, and as a function of VWbp(1-263) concentration, were analyzed by simultaneous nonlinear leastsquares fitting of the numerically integrated differential rate equations for candidate mechanisms with DYNAFIT (19) . The rate constants for initial binding of ProT and VWbp and binding of substrate were assumed to be diffusion controlled (10 8 M Ϫ1 s Ϫ1 ) rapid equilibrium steps. Fbn Turbidity Assays. Cleavage of Fbg by either thrombin, ProT⅐SC(1-325), or ProT⅐VWbp(1-263) complexes was monitored from the increase in turbidity at 450 nm at 25°C in the above-described buffer by using a microtiter plate reader. Fbg was added (0.5 mg/mL) to various concentrations of VWbp(1-263), 10 nM SC(1-325), or buffer, and reactions were started immediately by addition of 10 nM ProT or thrombin.
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Previous studies of conformational activation of ProT by staphylocoagulase (SC) (1) and its fully active fragment SC(1-325) (2) showed that activation was associated with slow autocatalytic cleavage of ProT. Early studies demonstrated that at micromolar concentrations of ProT and SC, cleavage at the thrombinsensitive Arg 155 -Ser 156 bond in ProT to form prethrombin 1 (Pre 1) and fragment 1 (F1) was accompanied by a large increase in fluorogenic substrate (Boc-Val-Pro-Arg-4-methylcoumaryl-7-amide) hydrolysis that was concluded to represent higher activity of the Pre 1⅐SC complex compared with the ProT⅐SC complex (1). These studies, performed at 0°C, reported that bovine fibrinogen clotting activity was generated in Ͻ5 min, whereas maximum fluorogenic substrate activity was observed at 60 min. This slow time dependence was not observed with Pre 1, for which clotting and fluorogenic substrate activity were both rapidly formed on addition of SC. Studies of SC(1-325) at micromolar concentrations and at 25°C in the same buffer used in the VWbp experiments, showed that formation of Pre 1 was followed by much slower generation of prethrombin 2Ј (Pre 2Ј) and fragment 2 (F2) resulting from cleavage of the second thrombin-sensitive bond in ProT at Arg 284 -Thr 285 (2) . The kinetics of ProT activation by SC(1-325) at nanomolar concentrations, after preincubation in the absence of substrate for 20 min, were inconsistent with the Pre 1⅐SC(1-325) complex having significantly increased activity with a chromogenic substrate (D-Phe-Pip-Arg-pNA) compared with ProT⅐SC(1-325) (2) . On the basis of these previous studies, the possibility that autoproteolytic cleavage of ProT to Pre 1 in mixtures with VWbp accounted for the observed hysteretic kinetics of ProT activation by VWbp was investigated by SDS-gel electrophoresis, Western blotting with a polyclonal anti-ProT antibody, and analysis of activation progress curves.
Results and Discussion. Proteolysis in mixtures of 10 M VWbp(1-263) and 5 M ProT was assessed by SDS-gel electrophoresis (Fig. S1 ). ProT was initially cleaved to Pre 1 and fragment 1 slowly over 180 min, with much smaller accumulation of Pre 2Ј. Incubation for 24 h resulted in full conversion of ProT and Pre 1 to Pre 2Ј, fragment 1, and fragment 2.
Western blotting was used to quantitate the autocatalytic cleavage of ProT in the presence of VWbp under conditions identical to those used for the full time-course progress curve experiments (Fig. 3 in the main text) . Samples were removed from mixtures of 1 nM ProT and 10 M VWbp(1-263) that were preincubated for 20 min before continued incubation in the absence or presence of 200 M D-Phe-Pip-Arg-pNA or TosylGly-Pro-Arg-pNA (Fig. S2) . At the highest VWbp concentration used in the progress curve experiments (10 M), 20% of ProT was converted into Pre 1 during the 20-min preincubation, which increased in the absence of substrate to 59% after 60 min (Fig.  S2 A and D) . The experiment in which D-Phe-Pip-Arg-pNA was added after 20-min preincubation showed a similar, 29% conversion to Pre 1, which remained essentially constant between 13% and 28% after addition of substrate for the subsequent 30 min of incubation, the time during which the progress curve was collected (Fig. S2 B and D) . Similar results were obtained with Tosyl-Gly-Pro-Arg-pNA, with 18% conversion to Pre 1 during the preincubation, which remained nearly constant at 14-32% over the total 60-min incubation time (Fig. S2 C and D) . The possibility that Pre 1 generation was due to trace levels of thrombin in the ProT preparation was ruled out by the absence of ProT cleavage in the standards containing equimolar ProT and Pre 1 that were incubated under the same conditions (Fig.  S2, lanes S1 and S2) . Additional experiments performed at 1 nM ProT and 1 M VWbp, a concentration of VWbp more representative of the progress curve experiments, showed Ͻ5% conversion of ProT to Pre 1 in the 20-min preincubation period (Fig. S3 A and D) , which was similarly inhibited after addition of either of the 2 chromogenic substrates, reaching 1-10% after 60 min (Fig. S3 B-D) .
The results indicated that only a low level of 23 Ϯ 9% (mean and range) of ProT was converted to Pre 1 at the highest VWbp concentration used in the progress curve experiments. Much lower levels of 1-10% Pre 1 were generated at 1 M VWbp, conditions under which the progress curves were clearly hysteretic. The results support the conclusion that Pre 1 formation does not account for the concluded hysteretic mechanism.
To evaluate the effect of such low levels of Pre 1 on the progress curves, individual curves were collected after addition of substrate as a function of preincubation time of 1 nM ProT and 10 M VWbp in the absence of substrate (Fig. S4 A) . All of the progress curves, truncated at Յ5% substrate depletion for this analysis, were fit well by the hysteresis equation without significant deviations.
Analysis of the progress curves gave v 0 , the initial velocity, v f , the final velocity, and k obs , the apparent first-order rate constant. The dependence of these parameters on preincubation time, i.e., Pre 1 generation, showed no significant changes in v f and slight increases in v 0 and k obs (Fig. S4 B) . During the 20-min preincubation period, v 0 relative to v f increased by Յ6%, and k obs increased 1.3-fold. These values were compared with those obtained for 1 nM Pre 1 activation by 10 M VWbp as a function of preincubation time. Pre 1 activation by VWbp(1-263) also displays hysteresis, with k obs values 1.5-to 3-fold faster than ProT. Pre 1 showed essentially no changes in v 0 , v f , or k obs over 60 min (Fig. S4 C) . The final velocity (v f ) for Pre 1 activation was only Ϸ4% larger than that for ProT, indicating indistinguishable rates of hydrolysis of the chromogenic substrate by the Pre 1⅐VWbp and ProT⅐VWbp complexes. This contrasts the observations of Kawabata and coworkers (1) for SC and a fluorogenic substrate. As can be seen by the raw data (Fig. S4 A) , where the ordinate maximum represents 0.1A 405 nm , the indistinguishable chromogenic substrate activity of the Pre 1⅐VWbp and ProT⅐VWbp complexes, and the small effects of low levels of Pre 1 generation on the hysteresis parameters resulted in only modest changes in the shapes of the curves, which were within experimental error.
We conclude that the hysteretic kinetic behavior of ProT activation by VWbp cannot be accounted for by autocatalytic generation of Pre 1. The close correspondence between the best-fit parameters of the mechanism in Scheme 1 in the main text that are independent of both chromogenic substrates, K D , k C1 , and k C2 , strengthens the conclusion that relatively low levels of Pre 1 generation did not substantively affect the validity of the concluded hysteretic mechanism of ProT activation by VWbp.
Materials and Methods. SDS-gel electrophoresis and Western blotting.
Time-course reactions were performed in 50 mM Hepes, 110 mM NaCl, 5 mM CaCl 2 , 1 mg/ml PEG 8000 (pH 7.4) at 25°C. Samples were quenched directly into hot SDS treatment buffer containing 2-mercaptoethanol, boiled for 2 min, and separated on 4-15% gradient gels (Bio-Rad). The protein bands were transferred onto polyvinyldiene difluoride membranes in Tris-glycine buffer containing 10% (vol/vol) methanol, and the membranes were blocked for 2 h in 50 mM Tris, 150 mM NaCl (pH 7.5), 0.1% (vol/vol) Tween-20 (TBS-T) containing 5% (wt/vol) nonfat dry milk. The membranes were incubated with a 1:500 dilution of anti-ProT polyclonal antibody (ab48627; Abcam) overnight, washed with TBS-T, and incubated with goat anti-rabbit IRDye 680 (Li-Cor) for 2 h. After thorough washing of the membranes in TBS-T, the bands were visualized using a Li-Cor Odyssey Infrared Imaging System in the 700-nm detection channel. Image analysis and quantitation. The integrated intensity for each detected band was determined with the Odyssey Imager software (v3.0). The signal ratio for the equimolar mixtures of ProT and Pre 1 (S1, S2) was used to correct the intensity of the Pre 1 bands for each lane to that of ProT, and the percentage of each band relative to the total intensity of each lane was calculated. Progress curve analysis. Individual progress curves were collected in 50 mM Hepes, 110 mM NaCl, 5 mM CaCl 2 , 1 mg/ml PEG 8000 (pH 7.4) at 25°C, truncated to Յ5% substrate depletion, and fit by the hysteresis equation (Eq. 1) as described in Materials and Methods of the main text. Progress curves were collected as a function of preincubation time for mixtures of 10 M VWbp(1-263) and 1 nM ProT or Pre 1, initiated by addition of 200 M D-Phe-Pip-Arg-pNA. Fig. S1 . Proteolytic products generated in ProT-VWbp(1-263) mixtures assessed by SDS-gel electrophoresis. Nonreduced samples (7.2 g ProT) of mixtures of 5 M ProT and 10 M VWbp incubated at 25°C in 50 mM Hepes, 110 mM NaCl, 5 mM CaCl2, 1 mg/ml PEG 8000 (pH 7.4) were taken at the indicated times after mixing, subjected to electrophoresis on a SDS 4 -15% gradient gel, and stained with GelCode blue protein stain (Thermo Scientific). Bands representing ProT, Pre 1, Pre 2Ј, F1, and F2 are indicated. 
